21 reports of this reaction
4.3% of all ATROPA BELLADONNA reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for ATROPA BELLADONNA. There are 21 FDA adverse event reports linking ATROPA BELLADONNA to NAUSEA. This represents approximately 4.3% of all 489 adverse event reports for this drug.
Patients taking ATROPA BELLADONNA who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among ATROPA BELLADONNA users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for ATROPA BELLADONNA:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 21 FDA reports for ATROPA BELLADONNA. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 4.3% of all adverse event reports for ATROPA BELLADONNA, making it one of the most commonly reported side effect.
If you experience nausea while taking ATROPA BELLADONNA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.